Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study
- PMID: 38151451
- DOI: 10.1016/j.dld.2023.12.007
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study
Abstract
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has been traditionally associated with insulin resistance and obesity. Recently, pollutants have been shown to contribute to the development of MASLD. Given the global burden of MASLD, understanding whether pollutants are merely associated with steatosis or contribute to its progression to advanced chronic liver disease (ACLD) and hepatocellular carcinoma (HCC) is critical. Workers exposed to occupational toxicants represent an ideal population for assessing the potentially hazardous consequences of professional exposure. Confirming a link between occupational exposure and ACLD/HCC may not only provide further elements in understanding MASLD, but also contribute to preventive strategies for exposed workers.
Objective: This study aimed to assess the prevalence of self-reported occupational exposure to toxicants in patients with MASLD.
Methods: This hospital-based prospective pilot study included 201 patients with MASLD. Data on workplace toxicant exposure were collected systematically using a structured questionnaire. Subsequently, patients with ACLD and/or HCC (n = 55) were compared to controls (n = 146). Logistic regression analysis and propensity score models were used to investigate the associations between self-reported occupational exposure and ACLD and/or HCC.
Results: Patients with ACLD/HCC reported exposure to metals, halogenated refrigerants, pain/resins, and fuel emissions more often than the controls. After controlling for confounders, durations of 21-30 years and >30 years of occupational exposure to toxicants showed odds ratios (ORs) of 2.31 (95 % confidence interval [CI]: 1.09-4.88, p = 0.029) and 4.47 (95 % CI: 2.57-7.78, p<0.001), respectively.
Conclusions: In this pilot study, patients with MASLD complications were more likely to report workplace toxicant exposure. Our results warrant future multicentre confirmatory studies, as implementing prevention policies may reduce the risk of life-threatening diseases among exposed populations.
Keywords: Hepatocellular carcinoma; Liver cirrhosis; Pollution; Steatohepatitis.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of Interest The Authors declare that there is no conflict of interest.
Similar articles
-
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.Clin Gastroenterol Hepatol. 2024 Sep;22(9):1774-1789.e8. doi: 10.1016/j.cgh.2024.03.028. Epub 2024 Apr 10. Clin Gastroenterol Hepatol. 2024. PMID: 38604295 Review.
-
Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.J Gastroenterol Hepatol. 2024 Dec;39(12):2817-2825. doi: 10.1111/jgh.16727. Epub 2024 Aug 27. J Gastroenterol Hepatol. 2024. PMID: 39191435 Free PMC article.
-
Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study.Dig Dis. 2025;43(1):36-45. doi: 10.1159/000541945. Epub 2024 Oct 14. Dig Dis. 2025. PMID: 39401491 Free PMC article.
-
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.J Hepatol. 2023 Dec;79(6):1374-1384. doi: 10.1016/j.jhep.2023.08.018. Epub 2023 Aug 28. J Hepatol. 2023. PMID: 37647992
-
Roles of immune dysregulation in MASLD.Biomed Pharmacother. 2024 Jan;170:116069. doi: 10.1016/j.biopha.2023.116069. Epub 2023 Dec 25. Biomed Pharmacother. 2024. PMID: 38147736 Review.
Cited by
-
Polychlorinated Biphenyl Exposure Alters tRNA Transcriptome in High-Fat Diet-Fed Mouse Liver.Noncoding RNA. 2025 May 22;11(3):41. doi: 10.3390/ncrna11030041. Noncoding RNA. 2025. PMID: 40559619 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical